EditorialPublished 30 Apr 2022

Clinical Trials for Leukaemia patients

Authors: Maria Trent

European Journal of Clinical Oncology

Volume 4 · Issue 2 · Pages 31–33

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The cancer of the bone marrow and blood cells is known as leukaemia. Leukemia causes uncontrolled production of abnormal (malignant) blood cells in the bone marrow. The body's ability to make normal blood cells is harmed as a result of the unchecked growth and buildup of malignant cells, which can lead to profound anaemia, an inability to fight infections, and a decrease in platelet production, which can lead to bleeding issues. Despite the fact that there are several possible risk factors, safety limits, and tobacco smoking.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in European Journal of Clinical Oncology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEuropean Journal of Clinical Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Maria Trent”